Andreas Gerber
Operationeel Directeur bij APEIRON Biologics AG
Actieve functies van Andreas Gerber
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
APEIRON Biologics AG
 APEIRON Biologics AG BiotechnologyHealth Technology APEIRON Biologics AG operates as a clinical-stage company which engages in the discovery and development of novel cancer immunotherapies. The firm develops APN311, a therapeutic antibody to treat pediatric patients with neuroblastoma; APN301, an immunocytokine consisting of a humanized antibody genetically linked to two human IL-2 molecules; and APN401, a first-in-class autologous cellular therapy. The company was founded by Josef Penninger in 2005 and is headquartered in Vienna, Austria. | Operationeel Directeur | 01-06-2021 | - |
Loopbaan van Andreas Gerber
Opleiding van Andreas Gerber
| University of Basel | Doctorate Degree |
| University of St. Gallen | Masters Business Admin |
Statistieken
Internationaal
| Zwitserland | 3 |
| Oostenrijk | 2 |
Operationeel
| Chief Operating Officer | 1 |
| Doctorate Degree | 1 |
| Masters Business Admin | 1 |
Sectoraal
| Consumer Services | 3 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
APEIRON Biologics AG
APEIRON Biologics AG BiotechnologyHealth Technology APEIRON Biologics AG operates as a clinical-stage company which engages in the discovery and development of novel cancer immunotherapies. The firm develops APN311, a therapeutic antibody to treat pediatric patients with neuroblastoma; APN301, an immunocytokine consisting of a humanized antibody genetically linked to two human IL-2 molecules; and APN401, a first-in-class autologous cellular therapy. The company was founded by Josef Penninger in 2005 and is headquartered in Vienna, Austria. | Health Technology |
- Beurs
- Insiders
- Andreas Gerber
- Ervaring
